44911-0542 NDC - RECOVATONE (GLYCYRRHIZA GLABRA, KALI MURIATICUM, KALI PHOSPHORICUM, IODIUM, ZINCUM GLUCONICUM, PHOSPHORUS, ASCORBICUM ACIDUM, CALCIUM GLUCONATE, L-ARGININE, L-CARNITINE, L-ORNITHINE, MAGNESIA MURIATICA, MAGNESIUM GLUCONICUM DIHYDRICUM, MANGANESE GLUCONATE, NATRUM MURIATICUM, COBALT GLUCONATE, COPPER GLUCONATE, CREATINE, L-GLUTAMINE, L-LEUCINE, L-VALINE, POTASSIUM GLUCONATE, SELENIUM DIOXIDE, ADRENALINUM, BORON, CALCAREA PHOSPHORICA, FERRUM SULPHURICUM, MOLYBDENUM, NICCOLUM METALLICUM, SELENIUM METALLICUM,)

Drug Information

  • Product NDC: 44911-0542
  • Proprietary Name: Recovatone
  • Non Proprietary Name: Glycyrrhiza Glabra, Kali Muriaticum, Kali Phosphoricum, Iodium, Zincum Gluconicum, Phosphorus, Ascorbicum Acidum, Calcium Gluconate, L-Arginine, L-Carnitine, L-Ornithine, Magnesia Muriatica, Magnesium Gluconicum Dihydricum, Manganese Gluconate, Natrum Muriaticum, Cobalt Gluconate, Copper Gluconate, Creatine, L-Glutamine, L-Leucine, L-Valine, Potassium Gluconate, Selenium Dioxide, Adrenalinum, Boron, Calcarea Phosphorica, Ferrum Sulphuricum, Molybdenum, Niccolum Metallicum, Selenium Metallicum,
  • Active Ingredient(s): 6 [hp_X]/mL ARGININE; 6 [hp_X]/mL ASCORBIC ACID; 12 [hp_X]/mL BORON; 6 [hp_X]/mL CALCIUM GLUCONATE; 6 [hp_X]/mL CARNITINE; 14 [hp_X]/mL CHROMIUM; 8 [hp_X]/mL COBALTOUS GLUCONATE; 8 [hp_X]/mL COPPER GLUCONATE; 15 [hp_C]/mL CORTICOTROPIN; 8 [hp_X]/mL CREATINE; 3 [hp_X]/mL DIBASIC POTASSIUM PHOSPHATE; 10 [hp_X]/mL EPINEPHRINE; 12 [hp_X]/mL FERROUS SULFATE; 8 [hp_X]/mL GLUTAMINE; 1 [hp_X]/mL GLYCYRRHIZA GLABRA; 4 [hp_X]/mL IODINE; 8 [hp_X]/mL LEUCINE; 6 [hp_X]/mL MAGNESIUM CHLORIDE; 6 [hp_X]/mL MAGNESIUM GLUCONATE; 6 [hp_X]/mL MANGANESE GLUCONATE; 12 [hp_X]/mL MOLYBDENUM; 12 [hp_X]/mL NICKEL; 6 [hp_X]/mL ORNITHINE; 5 [hp_X]/mL PHOSPHORUS; 2 [hp_X]/mL POTASSIUM CHLORIDE; 8 [hp_X]/mL POTASSIUM GLUCONATE; 12 [hp_X]/mL SELENIUM; 8 [hp_X]/mL SELENIUM DIOXIDE; 6 [hp_X]/mL SODIUM CHLORIDE; 12 [hp_X]/mL STRONTIUM CARBONATE; 12 [hp_X]/mL TRIBASIC CALCIUM PHOSPHATE; 8 [hp_X]/mL VALINE; 12 [hp_X]/mL VANADIUM; 4 [hp_X]/mL ZINC GLUCONATE
  • Administration Route(s): ORAL
  • Dosage Form(s): LIQUID
  • Pharmacy Class(es): Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Allergens [CS]; Allergens [CS]; Amino Acid [EPC]; Amino Acids [CS]; Ascorbic Acid [CS]; Blood Coagulation Factor [EPC]; Blood Coagulation Factor [EPC]; Calcium [CS]; Calcium [CS]; Calculi Dissolution Agent [EPC]; Calculi Dissolution Agent [EPC]; Catecholamine [EPC]; Catecholamines [CS]; Cations; Divalent [CS]; Cations; Divalent [CS]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Cell-mediated Immunity [PE]; Copper Absorption Inhibitor [EPC]; Decreased Copper Ion Absorption [PE]; Dietary Proteins [CS]; Increased Coagulation Factor Activity [PE]; Increased Coagulation Factor Activity [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Histamine Release [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Increased Large Intestinal Motility [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Inhibition Small Intestine Fluid/Electrolyte Absorption [PE]; Magnesium Ion Exchange Activity [MoA]; Magnesium Ion Exchange Activity [MoA]; Magnetic Resonance Contrast Activity [MoA]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Activity [MoA]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Osmotic Laxative [EPC]; Paramagnetic Contrast Agent [EPC]; Phosphate Binder [EPC]; Phosphate Binder [EPC]; Phosphate Chelating Activity [MoA]; Phosphate Chelating Activity [MoA]; Plant Proteins [CS]; Potassium Compounds [CS]; Potassium Compounds [CS]; Potassium Salt [EPC]; Potassium Salt [EPC]; Standardized Chemical Allergen [EPC]; Standardized Chemical Allergen [EPC]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Stimulation Large Intestine Fluid/Electrolyte Secretion [PE]; Vitamin C [EPC]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Labeler Information

Field Name Field Value
Labeler Name: Energique, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:5/8/2020
End Marketing Date:7/11/2027

Package Information

No. Package Code Package Description Billing Unit
144911-0542-1120 mL in 1 BOTTLE, DROPPER (44911-0542-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC44911-0542The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMERecovatoneThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEGlycyrrhiza Glabra, Kali Muriaticum, Kali Phosphoricum, Iodium, Zincum Gluconicum, Phosphorus, Ascorbicum Acidum, Calcium Gluconate, L-Arginine, L-Carnitine, L-Ornithine, Magnesia Muriatica, Magnesium Gluconicum Dihydricum, Manganese Gluconate, Natrum Muriaticum, Cobalt Gluconate, Copper Gluconate, Creatine, L-Glutamine, L-Leucine, L-Valine, Potassium Gluconate, Selenium Dioxide, Adrenalinum, Boron, Calcarea Phosphorica, Ferrum Sulphuricum, Molybdenum, Niccolum Metallicum, Selenium Metallicum,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMELIQUIDThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE5/8/2020This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE7/11/2027This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMEEnergique, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEARGININE; ASCORBIC ACID; BORON; CALCIUM GLUCONATE; CARNITINE; CHROMIUM; COBALTOUS GLUCONATE; COPPER GLUCONATE; CORTICOTROPIN; CREATINE; DIBASIC POTASSIUM PHOSPHATE; EPINEPHRINE; FERROUS SULFATE; GLUTAMINE; GLYCYRRHIZA GLABRA; IODINE; LEUCINE; MAGNESIUM CHLORIDE; MAGNESIUM GLUCONATE; MANGANESE GLUCONATE; MOLYBDENUM; NICKEL; ORNITHINE; PHOSPHORUS; POTASSIUM CHLORIDE; POTASSIUM GLUCONATE; SELENIUM; SELENIUM DIOXIDE; SODIUM CHLORIDE; STRONTIUM CARBONATE; TRIBASIC CALCIUM PHOSPHATE; VALINE; VANADIUM; ZINC GLUCONATEAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH6; 6; 12; 6; 6; 14; 8; 8; 15; 8; 3; 10; 12; 8; 1; 4; 8; 6; 6; 6; 12; 12; 6; 5; 2; 8; 12; 8; 6; 12; 12; 8; 12; 4 
ACTIVE INGRED UNIT[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_C]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Adrenocorticotropic Hormone [CS], Adrenocorticotropic Hormone [EPC], Allergens [CS], Allergens [CS], Allergens [CS], Amino Acid [EPC], Amino Acids [CS], Ascorbic Acid [CS], Blood Coagulation Factor [EPC], Blood Coagulation Factor [EPC], Calcium [CS], Calcium [CS], Calculi Dissolution Agent [EPC], Calculi Dissolution Agent [EPC], Catecholamine [EPC], Catecholamines [CS], Cations, Divalent [CS], Cations, Divalent [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Copper Absorption Inhibitor [EPC], Decreased Copper Ion Absorption [PE], Dietary Proteins [CS], Increased Coagulation Factor Activity [PE], Increased Coagulation Factor Activity [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Increased Large Intestinal Motility [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Large Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Inhibition Small Intestine Fluid/Electrolyte Absorption [PE], Magnesium Ion Exchange Activity [MoA], Magnesium Ion Exchange Activity [MoA], Magnetic Resonance Contrast Activity [MoA], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Plant Allergenic Extract [EPC], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Activity [MoA], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Osmotic Laxative [EPC], Paramagnetic Contrast Agent [EPC], Phosphate Binder [EPC], Phosphate Binder [EPC], Phosphate Chelating Activity [MoA], Phosphate Chelating Activity [MoA], Plant Proteins [CS], Potassium Compounds [CS], Potassium Compounds [CS], Potassium Salt [EPC], Potassium Salt [EPC], Standardized Chemical Allergen [EPC], Standardized Chemical Allergen [EPC], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Stimulation Large Intestine Fluid/Electrolyte Secretion [PE], Vitamin C [EPC], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record record in Text format: Export

Download this NDC record record in Excel (CSV) format: Export

Download this NDC record record in XML format: Export

This page was last updated on: 11/21/2025

Previous Code
Next Code